| Literature DB >> 28471266 |
Silvana Cartaxo da Costa Urtiga1,2, Camilla Aquino Azevedo de Lucena Gabi2, Giovanna Rodrigues de Araújo Eleamen2, Bartolomeu Santos Souza1, Hilzeth de Luna Freire Pessôa3, Henrique Rodrigues Marcelino1, Elisângela Afonso de Moura Mendonça4, Eryvaldo Sócrates Tabosa do Egito1, Elquio Eleamen Oliveira2.
Abstract
This work describes the preparation and evaluation of safe xylan-based microparticles prepared by cross-linking polymerization using sodium trimetaphosphate. The resulting microparticles were evaluated for morphology, particle size, polymer-cross-link agent interaction, and in vitro toxicity. The microparticles showed narrow monodisperse size distributions with their mean sizes being between 3.5 and 12.5 µm in dried state. FT-IR analyzes confirmed the interaction between sodium trimetaphosphate and xylan during the cross-linking process with formation of phosphate ester bonds. Additionally, the X-ray diffraction patterns and FT-IR analyzes suggested that little or no cross-linking agent remained inside the microparticles. Furthermore, the in-vitro studies using Artemia salina and human erythrocytes revealed that the microparticles are not toxic. Therefore, the overall results suggest that these xylan microparticles can be used as a platform for new drug delivery system.Entities:
Keywords: Cross-linking reaction; microencapsulation; polymeric microparticles; sodium trimetaphosphate; toxicity assay
Mesh:
Substances:
Year: 2017 PMID: 28471266 DOI: 10.1080/03639045.2017.1326932
Source DB: PubMed Journal: Drug Dev Ind Pharm ISSN: 0363-9045 Impact factor: 3.225